Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review

The Journal of Dermatological Treatment
Pingjiao ChenJingyao Liang

Abstract

There is a few evidence-based information regarding the efficacy and safety of acitretin treatment in children with pustular psoriasis (PP). This study aimed to provide an additional evidence for this field. A retrospective study was undertaken for 15 children with PP who received acitretin in doses of 0.6-1.0 mg/kg/day for 4-6 weeks, the transition dose of 0.2-0.4 mg/kg/day for 4-6 weeks and maintenance dose of 0.2-0.3 mg/kg/day. Additionally, a literature review on this topic is conducted. Of 15 children with generalized PP (GPP, n = 10), palmoplantar psoriasis (PPP, n = 3), and acrodermatitis continua of Hallopeau (ACH, n = 2), 93.3% (14/15) showed good response, only one case with ACH exhibited moderate response. During the 10-32 months of follow-up, acitrerin monotherapy for children cases with PP overall showed good efficacy and safety. In the literature review, a total of 107 childhood PP cases treated with acitretin in 21 studies were included in the analysis. The clinical effectiveness was obtained in 88.8% (95/107) patients treated with acitretin as monotherapy or combination therapy, and most of cases (92.6%, 100/107) treated by acitretin did not report side effects during the treatment and follow-up of acitretin. Th...Continue Reading

References

Oct 1, 1992·The British Journal of Dermatology·D G PaigeJ I Harper
Sep 1, 1988·Journal of the American Academy of Dermatology·H GollnickE Hoting
Dec 1, 1988·The British Journal of Dermatology·A Lassus, J M Geiger
May 1, 1987·The British Journal of Dermatology·M T GloverD J Atherton
Sep 1, 1995·Pediatric Dermatology·M SallerasP Umbert
Apr 21, 1999·The Journal of Dermatology·A OzawaH Ogawa
Dec 21, 2000·The British Journal of Dermatology·S P LiS N Wong
Apr 27, 2002·Journal of Cutaneous Medicine and Surgery·Danielle Marcoux, Yves Prost
May 27, 2005·Pediatric Dermatology·Carlo MazzatentaRaffaele Domenici
Jan 13, 2006·The British Journal of Dermatology·M PapoutsakiS Chimenti
Dec 1, 2006·Dermatology : International Journal for Clinical and Investigative Dermatology·Teresa M PereiraA Sousa Basto
May 15, 2007·Proceedings of the American Thoracic Society·Duncan J Macrae
Jun 15, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·X FanX-J Zhang
Jul 9, 2008·The Journal of Dermatological Treatment·Sibel ErginOzay Ozkaya
Jul 9, 2008·The Journal of Dermatological Treatment·Xi-Bao ZhangXiao Xu
Mar 3, 2009·Pediatric Dermatology·Ana Elisa KiszewskiNelson Ricachnevsky
May 28, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·E AdişenM A Gürer
Aug 27, 2009·Pediatric Dermatology·Pei-Hsin ChaoMei-Yung Chung
Nov 11, 2009·Journal of the American Academy of Dermatology·Michelle E A de JagerMarieke M B Seyger
Dec 10, 2009·Expert Opinion on Drug Safety·Chai Sue Lee, Kai Li
Apr 21, 2010·Pediatric Dermatology·Sarah Toyomi de OliveiraRicardo Romiti
Mar 17, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·E SbidianH Bachelez
Apr 21, 2011·Pediatric Dermatology·Antonio Chaves AlvarezAntonio Zambrano
May 23, 2012·Journal of the American Academy of Dermatology·Amanda RobinsonRobert E Kalb
Apr 6, 2013·Dermatologic Clinics·Ann L Marqueling, Kelly M Cordoro
Oct 9, 2013·Dermatologic Therapy·Noelani E Gonzalez OrtizJeffrey M Weinberg
Mar 8, 2014·Pediatric Dermatology·Svetlana Popadic, Milos Nikolic
Apr 8, 2014·Dermatologic Therapy·Jorga FialováJana Hercogová
Jun 4, 2014·Pediatric Dermatology·Claudia J Posso-De Los RiosIrene Lara-Corrales
May 6, 2015·Current Pediatric Reviews·UNKNOWN Matteo Megna and Maddalena NapolitanoNicola Balato
Jun 15, 2015·Paediatric Drugs·I M G J BronckersM M B Seyger
Jul 16, 2016·Cell Host & Microbe·Tyler A Rice, Noah W Palm
Dec 21, 2016·The Journal of Dermatological Treatment·Victoria HaugHenning Hamm
Jan 9, 2017·Journal of Dermatological Science·Yirong WangZhirong Yao

❮ Previous
Next ❯

Citations

Jul 5, 2019·Expert Opinion on Pharmacotherapy·S D'AdamioM Galluzzo
Jul 24, 2020·Dermatologic Therapy·Angelo RuggieroGabriella Fabbrocini
Feb 6, 2020·Paediatric Drugs·Yi-Wei Huang, Tsen-Fang Tsai
Sep 21, 2019·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Lisa EisertMichael Sticherling
Sep 21, 2019·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Lisa EisertMichael Sticherling
Feb 20, 2021·Psoriasis : Targets and Therapy·Morten B HaulrigLone Skov
Jan 22, 2022·American Journal of Clinical Dermatology·James KruegerDiamant Thaçi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Atti della Società italiana di dermatologia e sifilografia e delle sezioni interprovinciali
F ALLEGRA, M JORI
© 2022 Meta ULC. All rights reserved